Vivani Medical Stock Quote VANI - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.305

Bid

1.30

Ask

1.31

Volume

229,372

1.29 Day's Range 1.3195

0.84 52 Week Range 7.80

Market Cap

68.723M

Previous Close

1.25

Open

1.31

Last Trade

1.3095

Last Trade Time

09:56:06

Financial Volume

$ 299,657

VWAP

1.3064

Average Volume (3m)

383,596

Shares Outstanding

54,978,465

Dividend Yield

PE Ratio

-2.68

Earnings Per Share (EPS)

-0.47

Revenue

Net Profit

-25.65M

Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need.

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

www.vivani.com

Headquarters

Emeryville, California, USA

Founded

1970

Vivani Medical Inc is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker VANI. The last closing price for Vivani Medical was $1.25. Over the last year, Vivani Medical shares have traded in a share price range of $ 0.84 to $ 7.80.

Vivani Medical currently has 54,978,465 shares outstanding. The market capitalization of Vivani Medical is $68.72 million. Vivani Medical has a price to earnings ratio (PE ratio) of -2.68.

Form 8-K - Current report

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani expects to initiate the first clinical study supporting the NPM-115 program in the fourth quarter of 2024 The NPM-115 clinical program will consist of a series of studies designed to...

Form 8-K - Current report

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

NPM-119 is being studied to address medication non-adherence and potentially improve tolerability issues associated with oral and injectable type 2 diabetes medications, by providing long-term...

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.095	7.85123966942	1.21	1.32	1.2096	59450	1.24854331	CS
4	-0.475	-26.6853932584	1.78	2.09	1.2	996644	1.57566091	CS
12	-0.545	-29.4594594595	1.85	2.09	1.2	383596	1.60679537	CS
26	0.245	23.1132075472	1.06	7.8	1.01	1748380	3.45153387	CS
52	0.005	0.384615384615	1.3	7.8	0.84	881403	3.39340954	CS
156	-2.895	-68.9285714286	4.2	7.8	0.7536	508129	3.27914449	CS
260	-2.895	-68.9285714286	4.2	7.8	0.7536	508129	3.27914449	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KZIAKazia Therapeutics Ltd	$ 1.28 (91.56%)	101.07M
LCFYLocafy Ltd	$ 4.20 (81.03%)	351.42k
BDRXBiodexa Pharmaceuticals PLC	$ 1.26 (77.19%)	43.73M
VLCNVolcon Inc	$ 6.16 (68.77%)	18.26M
ISPCiSpecimen Inc	$ 0.4801 (67.93%)	18.98M
CINGCingulate Inc	$ 0.491 (-24.23%)	670.07k
CETUUCetus Capital Acquisition Corporation	$ 7.58 (-23.90%)	305
IVPInspire Veterinary Partners Inc	$ 5.84 (-21.08%)	978.3k
SLRXSalarius Pharmaceuticals Inc	$ 2.23 (-18.69%)	1.63M
CLNNClene Inc	$ 4.61 (-17.97%)	31.61k
KZIAKazia Therapeutics Ltd	$ 1.27 (90.06%)	101.08M
RNLXRenalytix PLC	$ 0.414 (37.13%)	58.3M
NVDANVIDIA Corporation	$ 133.525 (-1.03%)	55.17M
MAXNMaxeon Solar Technologies Ltd	$ 0.19979 (-5.22%)	54.73M
BDRXBiodexa Pharmaceuticals PLC	$ 1.26 (77.19%)	43.73M